Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Federated Hermes Kaufmann Fund is a prominent mutual fund that focuses on capital appreciation by investing primarily in small- and mid-cap growth companies. While not a biotechnology company itself, the fund is a significant institutional investor in the life sciences, healthcare, and biotechnology sectors, often participating in initial public offerings and private placements. It is managed by Federated Hermes and is known for its aggressive growth strategy and deep expertise in identifying emerging healthcare innovators. The fund's portfolio typically includes a high concentration of companies involved in drug discovery, medical devices, and healthcare services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kauffmann Funds.